Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Mar;24(2):167-9.

[Double-pump implantation chemotherapy for hepatic metastasis from colorectal cancer]

[Article in Chinese]
Jianmiao He  1 , Yongdong Pu, Zhidong Zhu, Zhiyu Cao, Bo Yang, Liguo Dong
Affiliations
  • PMID: 12015040

[Double-pump implantation chemotherapy for hepatic metastasis from colorectal cancer]

[Article in Chinese]
Jianmiao He et al. Zhonghua Zhong Liu Za Zhi. 2002 Mar.

Abstract

Objective: To evaluate the value of infusion chemotherapy by pump implantation via hepatic artery or portal vein or both (double-pump chemotherapy, DPC) for hepatic metastasis from colorectal cancer.

Methods: Thirty patients with hepatic metastasis from colorectal cancer were divided into three groups: 1. Group I-DPC (12 patients). 2. Group II-hepatic artery implantation chemotherapy (10 patients) and 3. Group III-portal vein implantation chemotherapy (8 patients).

Results: Response rate was 66.7% in group I, 60% in group II and 37.5% in group III. The 0.5-, 1-, 2-year survival rates were 100.0%, 75.0%, 41.7% in group I, 90.0%, 60.0%, 30.0% in group II and 87.5%, 50.0%, 25.0% in group III.

Conclusion: Double pump implantation chemotherapy is effective in treating hepatic metastasis from colorectal cancer. It is better than hepatic artery or portal vein pump-implantation chemotherapy alone.

PubMed Disclaimer

Publication types